Explore more publications!

Latest News

Labels On
FILTER THE FEED
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
FILTER THE FEED
Source Label Filters

Select the labels to control what appears in your feed.

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
MercyOne Traer Family Medicine to shutter Dec. 10

MercyOne Traer Family Medicine to shutter Dec. 10

Indeterminate North Tama Telegraph - Iowa
Owner: Ogden-Nutting Family
LiveSpo and the Pharmacy Community Advance Solutions to Reduce Antibiotics Abuse

LiveSpo and the Pharmacy Community Advance Solutions to Reduce Antibiotics Abuse

Sudeep Pharma Share Debuts At Rs 730 On NSE With 23% Premium, Should You Buy, Hold Or Sell?

Sudeep Pharma Share Debuts At Rs 730 On NSE With 23% Premium, Should You Buy, Hold Or Sell?

Sudeep Pharma shares rally 8% after solid listing pop. Should you buy, sell or hold?

Sudeep Pharma shares rally 8% after solid listing pop. Should you buy, sell or hold?

Emcure Pharma shares in focus after GST Department conducts search at Mumbai offices

Emcure Pharma shares in focus after GST Department conducts search at Mumbai offices

Why traditional medicine practitioners should unite, meet WHO’s standards – Nakowa

Why traditional medicine practitioners should unite, meet WHO’s standards – Nakowa

Sudeep Pharma shares zoom 31% above ₹593-IPO price after stellar listing

Sudeep Pharma shares zoom 31% above ₹593-IPO price after stellar listing

Sudeep Pharma Share Price Highlights: Shares soar after premium listing

Sudeep Pharma Share Price Highlights: Shares soar after premium listing

Neutral The Hindu Business Line
Owner: The Kasturi Family
Little boy with cough dies after doctors 'give him wrong dose' of medication

Little boy with cough dies after doctors 'give him wrong dose' of medication

Left-wing The Mirror
Owner: Reach PLC
LiveSpo and the Pharmacy Community Advance Solutions to Reduce Antibiotics Abuse

LiveSpo and the Pharmacy Community Advance Solutions to Reduce Antibiotics Abuse

Sudeep Pharma Share Debuts At Rs 730 On NSE With 23% Premium, Should You Buy, Hold Or Sell?

Sudeep Pharma Share Debuts At Rs 730 On NSE With 23% Premium, Should You Buy, Hold Or Sell?

Sudeep Pharma shares rally 8% after solid listing pop. Should you buy, sell or hold?

Sudeep Pharma shares rally 8% after solid listing pop. Should you buy, sell or hold?

Emcure Pharma shares in focus after GST Department conducts search at Mumbai offices

Emcure Pharma shares in focus after GST Department conducts search at Mumbai offices

Why traditional medicine practitioners should unite, meet WHO’s standards – Nakowa

Why traditional medicine practitioners should unite, meet WHO’s standards – Nakowa

Sudeep Pharma shares zoom 31% above ₹593-IPO price after stellar listing

Sudeep Pharma shares zoom 31% above ₹593-IPO price after stellar listing

Sudeep Pharma Share Price Highlights: Shares soar after premium listing

Sudeep Pharma Share Price Highlights: Shares soar after premium listing

Little boy with cough dies after doctors 'give him wrong dose' of medication

Little boy with cough dies after doctors 'give him wrong dose' of medication

MercyOne Traer Family Medicine to shutter Dec. 10

MercyOne Traer Family Medicine to shutter Dec. 10

Show More

Video Stories

YouTube video thumbnail: New Technology Helps Paralyzed Patients Move
Play
New Technology Helps Paralyzed Patients Move
YouTube video thumbnail: Medicare Announces Price Cuts for Ozempic and Other Prescription Drugs
Play
Medicare Announces Price Cuts for Ozempic and Other Prescription Drugs
YouTube video thumbnail: Whooping Cough Cases Surge as Vaccination Levels Drop
Play
Whooping Cough Cases Surge as Vaccination Levels Drop
YouTube video thumbnail: Music Therapy Helps Chinese Elders in Boston Overcome Trauma
Play
Music Therapy Helps Chinese Elders in Boston Overcome Trauma

Video Title

Press Releases

Show More
Your brand’s story is being written — with or without you.
We’re the leading press release service for mid-sized businesses & organizations built for the AI era.
Learn more

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions